Above and below knee femoropopliteal VIABAHN®

Catheterization and Cardiovascular Interventions

Volumn 85, Issue 5, 2015, Pages 859-867

  Shackles, Christopher ^a   Rundback, John H ^b   Herman, Kevin ^b   David, Yitzchak ^b   Barkarma, Ravit ^b  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^b Holy Name Medical Center   (United States)

Author keywords

critical limb ischemia; popliteal; VIABAHN

Indexed keywords

POLITEF;

ADULT; AGED; ANATOMICAL VARIATION; ARTICLE; BALLOON DILATATION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CRITICAL LIMB ISCHEMIA; ENDOVASCULAR SURGERY; FEMALE; FEMUR CONDYLE; FOLLOW UP; HEMODYNAMICS; HUMAN; KNEE; LEG THROMBOSIS; LIMB AMPUTATION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPLITEAL ARTERY; RESTENOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; STENT FRACTURE; VASCULAR PATENCY; VASCULAR STENT; ARTERIAL OCCLUSIVE DISEASES; BLOOD VESSEL PROSTHESIS; FEMORAL ARTERY; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; PROSTHESIS; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ARTERIAL OCCLUSIVE DISEASES; BLOOD VESSEL PROSTHESIS; ENDOVASCULAR PROCEDURES; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; POPLITEAL ARTERY; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 84925337783     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25666     Document Type: Article

References (24)

1. Criqui MH, Fronek A, Barrett-Connor E, et al. The prevalence of peripheral arterial disease in a defined population. Circulation 1985; 71: 510-551.
2. Hiatt WR, Hoag S, Hamman RF,. Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study. Circulation 1995; 91: 1472-1479.
3. Rutherford RB, Baker JD, Ernst C, et al. Recommended standards for report dealing with lower extremity ischemia revised version. J Vasc Surg 1997; 26: 517-538.
4. McQuade K, Gable D, Hohman S, et al. Randomized comparison of ePTFE/nitinol selfexpanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. J Vasc Surg 2009; 49: 109-116.
5. Schillinger M, Sabeti S, Dick P, et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 2007; 115: 2745-2749.
6. Bosiers M, Deloose K, Callaert J, et al. Results of the protégé Everflex 200 mm long nitinol stent (ev3) in TASC C and D femoropopliteal lesions. J Vasc Surg 2011; 54; 1042-1050.
7. Schlager O, Dick P, Sabeti S, et al. Long-segment SFA stenting-The dark sides: In-stent restenosis, clinical deterioration, and stent fractures. J Endovasc Ther 2005; 12: 676-684.
8. Saxon RR, Coffman JM, Gooding JM, et al. Long-term results of ePTFE stent-graft versus angioplasty in the femoropopliteal artery: Single center experience from a prospective, randomized trial. J Vasc Interv Radiol 2003; 14: 303-311.
9. Saxon RR, Dake M, Volgelzang R, et al. Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease. J Vasc Interv Radiol 2008; 19: 823-832.
10. Saxon RR, Coffman J, Gooding JM, et al. Long-term patency and clinical outcome of the Viabahn stent-graft for femoropopliteal artery obstructions. J Vasc Interv Radiol 2007; 18: 1341-1349.
11. Mewissen M,. Single center and multicenter results (VIBRANT Trial) of VIABAHN StentGrafts vs. uncovered nitinol stents for SFA occlusive disease. Abstract presented at: 36th Annual VEITH Symposium; November 19, 2009; New York, NY.
12. Bosiers M, Deloose K, Verbist J, et al. Heparin-bonded expanded polytetrafluoroethylene vascular graft for femoropopliteal and femorocrural bypass grafting: 1-year results. J Vasc Surg 2006; 43: 313-318;discussion 318-319.
13. Kedora J, Hohmann S, Garrett W, et al. Randomized comparison of percutaneous VIABAHN stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease. J Vasc Surg. 2007; 45: 10-16.
14. Jahnke T, Andresen R, Müller-Hülsbeck S, et al. Hemobahn stent-grafts for treatment of femoropopliteal arterial obstructions: Midterm results of a prospective trial. J Vasc Interv Radiol 2003; 14: 41-51.
15. Lammer J, Zeller T, Hausegger K, et al. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions. J Am Coll Cardiol 2013; 65: 1320-1327.
16. Tamashiro GA, Tamashiro A, Villegas MO, et al. Flexions of the popliteal artery: Technical considerations of femoropopliteal stenting. J Invasive Cardiol 2011; 23: 431-433.
17. Alimi YS, Hakam Z, et al. Efficacy of Viabahn in the treatment of severe superficial femoral artery lesions; which factors influence long term patency? Eur J Vasc Endovasc Surg 2008; 35: 346-352.
18. Wiesinger B, Beregi JP, Oliva VL, et al. PTFEcovered self-expanding nitinol stents for the treatment of severe iliac and femoral artery stenosis and occlusions: Final results from a prospective study. J Endovasc Ther 2005; 12: 240-246.
19. Fischer M, Schwabe C,., Schulte KL,. Value of hemobahn/viabahn endoprosthesis in the treatment of long chronic lesions of the superficial femoral artery: 6 years experience. J Endovasc Ther 2006; 13: 281-290.
20. Kuhan G, Abisi S, Braithwaite BD, et al. Early results with the use of heparin-bonded stent graft to rescue failed angioplasty of chronic femoropopliteal occlusive lesions: TASC D lesions have a poor outcome. Cardiovasc Intervent Radiol 2012; 35: 1023-1028.
21. Schneider JR, Verta MJ, Alonzo M, et al. Results with VIABAHN-assisted subintimal recanalization for TASC C and TASC D superficial femoral artery occlusive disease. Vasc Endovasc Surg 2011; 45: 391-397.
22. Boufi M, Dona B, Orsini B, et al. A comparison of the standard Bolia technique versus subintimal recanalization plus VIABAHN stent graft in the management of femoro-popliteal occlusions of 34 limbs treated with subintimal Viabahn placement. J Vasc Surg 2010; 52: 1211-1217.
23. Saxon RR, Chervu A, Jones PA, et al. Heparin-bonded, expanded polytetrafluoroethylene-lined stent graft in the treatment of femoropopliteal artery disease: 1-year results of the VIPER (VIABAHN Endoprosthesis with Heparin Bioactive Surface in the Treatment of Superficial Femoral Artery Obstructive Disease) trial. J Vasc Interv Radiol 2013; 24: 165-173.
24. Johnston PC, Vartanian SM, Runge SJ, et al. Risk factors for clinical failure after stent graft treatment for femoropopliteal occlusive disease. J Vasc Surg 2012; 56: 998-1007.